focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Thanks for the links to the framework agreement.
It certainly does appear that FDBK is front runner in its area and will be part of the £360 million deal.
This is getting very exciting and surprisingly still flying under radar.
My thinking may be biased as I am a holder here but if you listen to TO’s recent Sunday Roast interview, he seems to be describing a new NHS system which seems to fit exactly with the weekend media articles on the same subject.
There could be a transformational moment coming if this is Bleepa.
1.5 billion scans a year in the UK. I am fairly certain Tom mentioned £2/scan!
Agreed.
With the company cash rich and no threat of a placing, I expect more positive moves higher upon news flow.
And I think we will see plenty going forward.
One foot into the CDC programme should turn into a stampede.
I believe the market is starting to look ahead and beginning to price in a Bleepa technology platform making the NHS digital and fit for the future.
This alone represents a massive opportunity never mind India and everything else.
Most exciting medical company on AIM that should rise like those covid hot stocks.
A nice simple way of looking at the situation developing here. Thanks for that.
That is something like 60-70p on the share price minimum and as you say the resource is almost certainly set to grow massively.
Waiting game here as many say but at some point of the cycle, big investors will have to take positions. Well, a few already have recently.
Perhaps a covid type lucky stock that goes ballistic.
Certainly in with a good chance having been selected as the tech partner in the new community hubs initiative trial.
NHS waiting list could exceed ten million, a solution is needed ASAP and Bleepa fits the bill.
Adoption still early days but it has morphed into much more than just an imaging app and is now actually looking very useful.